VIRACEPT (AGOURON)


Welcome to the PulseAid listing for the VIRACEPT drug offered from AGOURON. This HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AGOURON
NON-PROPRIETARY NAME: nelfinavir mesylate
SUBSTANCE NAME: NELFINAVIR MESYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1997-03-14
END MARKETING DATE: 0000-00-00


VIRACEPT HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVIRACEPT from AGOURON
LABELER NAME: AGOURON
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 1997-03-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63010-010_6abd808e-1f03-4211-b294-6f596e2585aa
PRODUCT NDC: 63010-010
APPLICATION NUMBER: NDA020779

Other NELFINAVIR MESYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AGOURONVIRACEPT
H.J. Harkins Company, Inc.VIRACEPT
PD-Rx Pharmaceuticals, Inc.VIRACEPT
State of Florida DOH Central PharmacyViracept